655 related articles for article (PubMed ID: 23021243)
21. Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer.
Ma S; Qu W; Mao L; Zhu Z; Jia L; Zhao L; Zheng X
Oncol Rep; 2012 May; 27(5):1443-50. PubMed ID: 22294034
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy progress and prospects cancer: oncolytic viruses.
Liu TC; Kirn D
Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413
[TBL] [Abstract][Full Text] [Related]
23. Advance in herpes simplex viruses for cancer therapy.
Liu S; Dai M; You L; Zhao Y
Sci China Life Sci; 2013 Apr; 56(4):298-305. PubMed ID: 23564184
[TBL] [Abstract][Full Text] [Related]
24. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
[TBL] [Abstract][Full Text] [Related]
25. Oncolytic virotherapy for cancer treatment: challenges and solutions.
Davis JJ; Fang B
J Gene Med; 2005 Nov; 7(11):1380-9. PubMed ID: 16025557
[TBL] [Abstract][Full Text] [Related]
26. Cancer gene therapy with oncolytic adenoviruses.
Guse K; Hemminki A
J BUON; 2009 Sep; 14 Suppl 1():S7-15. PubMed ID: 19785073
[TBL] [Abstract][Full Text] [Related]
27. Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy.
Choi JW; Kang E; Kwon OJ; Yun TJ; Park HK; Kim PH; Kim SW; Kim JH; Yun CO
Gene Ther; 2013 Sep; 20(9):880-92. PubMed ID: 23514707
[TBL] [Abstract][Full Text] [Related]
28. Comparison of oncolytic adenoviruses for selective eradication of oral cancer and pre-cancerous lesions.
van Zeeburg HJ; Huizenga A; Brink A; van den Doel PB; Zhu ZB; McCormick F; Brakenhoff RH; van Beusechem VW
Gene Ther; 2010 Dec; 17(12):1517-24. PubMed ID: 20686507
[TBL] [Abstract][Full Text] [Related]
29. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
[TBL] [Abstract][Full Text] [Related]
30. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X
J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.
Palmer DH; Chen MJ; Searle PF; Kerr DJ; Young LS
Gene Ther; 2005 Aug; 12(15):1187-97. PubMed ID: 15800660
[TBL] [Abstract][Full Text] [Related]
32. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
[TBL] [Abstract][Full Text] [Related]
33. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
Liu X; Cao X; Wei R; Cai Y; Li H; Gui J; Zhong D; Liu XY; Huang K
Cancer Gene Ther; 2012 Jan; 19(1):49-57. PubMed ID: 21979578
[TBL] [Abstract][Full Text] [Related]
34. Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice.
Ganesh S; Gonzalez Edick M; Idamakanti N; Abramova M; Vanroey M; Robinson M; Yun CO; Jooss K
Cancer Res; 2007 May; 67(9):4399-407. PubMed ID: 17483354
[TBL] [Abstract][Full Text] [Related]
35. Selectively replicating oncolytic adenoviruses as cancer therapeutics.
Yu DC; Working P; Ando D
Curr Opin Mol Ther; 2002 Oct; 4(5):435-43. PubMed ID: 12435044
[TBL] [Abstract][Full Text] [Related]
36. Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.
Fujiwara T; Shirakawa Y; Kagawa S
Expert Rev Anticancer Ther; 2011 Apr; 11(4):525-32. PubMed ID: 21504319
[TBL] [Abstract][Full Text] [Related]
37. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
Bauzon M; Hermiston TW
Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
[TBL] [Abstract][Full Text] [Related]
38. Oncolytic HSV as a vector in cancer immunotherapy.
Li H; Zhang X
Methods Mol Biol; 2010; 651():279-90. PubMed ID: 20686972
[TBL] [Abstract][Full Text] [Related]
39. [Construction of an oncolytic adenovirus expressing small hairpin RNA and targeting the SATB1 gene].
Mao LJ; Zheng JN; Li W; Wang JQ; Chen JC; Sun XQ
Zhonghua Nan Ke Xue; 2010 Aug; 16(8):679-83. PubMed ID: 21090340
[TBL] [Abstract][Full Text] [Related]
40. Oncolytic adenoviruses: design, generation, and experimental procedures.
Davydova J; Yamamoto M
Curr Protoc Hum Genet; 2013 Jul; Chapter 12():Unit 12.14. PubMed ID: 23853080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
